Clinical Trial Update: The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study [Phase 4]

View source ↗

Summary

Phase 4 real-world study assessing safety and efficacy of luspatercept in Chinese adults with transfusion-dependent thalassemia (beta-thalassemia major).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major
• Transfusion-dependent Anemia

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Thalassemia Major, Transfusion-dependent Anemia | Phase 4 | Status: UNKNOWN